Testing a New Imaging Agent to Identify Cancer
Testing a New Imaging Agent to Identify Cancer
Active, not recruiting · NCT04692831 · Registry updated 2026-07-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Testing a New Imaging Agent to Identify Cancer | HER-2 Positive Malignant Carcinoma of Breast; HER-2 Protein Overexpression; HER2-positive Metastatic Breast Cancer | Active, not recruiting | Phase 1 | 2026-07-13 | NCT04692831 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 753 |
| National Institutes of Health (NIH) | 667 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) | Basking Ridge | United States | 46 |
| Memorial Sloan Kettering Bergen (Limited Protocol Activities) | Montvale | United States | 184 |
| Memorial Sloan Kettering Cancer Center (All Protocol Activities) | New York | United States | 230 |
| Memorial Sloan Kettering Monmouth (Limited Protocol Activities) | Middletown | United States | 186 |
| Memorial Sloan Kettering Nassau (Limited Protocol Activites) | Rockville Centre | United States | 29 |
| Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity) | Commack | United States | 12 |
| Memorial Sloan Kettering Westchester (Limited Protocol Activities) | Harrison | United States | 166 |